Back to Top
RMP1-14
-
-
September 01, 2023
Introduction ...
-
April 22, 2022
Introduction
In advancing cancer immunotherapy, antibodies against PD-1 have become a breakthrough and opened a new door for severely affected cancer patients. Nevertheless, the results of preclinical studies have faced various obstacles in transforming into successful clinical...
